Your session is about to expire
← Back to Search
Magnap for Obstructive Sleep Apnea (MAGNAP Trial)
MAGNAP Trial Summary
This trial will study whether the Magnap device is a safe and effective treatment for people with obstructive sleep apnea.
MAGNAP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMAGNAP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MAGNAP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My eligibility is not affected by my gender, race, or ethnicity.My sleep apnea is not caused by tongue position, but by other factors.I am between 21 and 70 years old.I have moderate to severe sleep apnea.I can't tolerate CPAP therapy for my sleep, using it less than 2 hours per night.
- Group 1: Treatment Arm with Magnetic Apnea Device
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I eligible to participate in this research project?
"Those hoping to enroll in this clinical trial must have been diagnosed with obstructive sleep apnea (OSA) and be aged between 21 and 70. Currently, around 10 individuals are being recruited for the study."
Is the demographic of this trial inclusive to individuals over four decades old?
"Patients over the age of majority and under 70 years old are welcomed to join this clinical trial."
How many participants are currently enrolled in this research endeavor?
"Affirmative. Data hosted on clinicaltrials.gov confirms that this medical trial, first posted September 1st 2015, is actively accepting participants. 10 individuals are required to join the study at a single location."
Are there any available vacancies in this trial for participants?
"Absolutely. According to clinicaltrials.gov, the trial is currently open for enrollment and was first launched on September 1st 2015. The most recent update occurred on November 2nd 2022 and it requires 10 individuals from one location."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger